Potent in vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin L

The emergence of SARS-CoV-2 in late 2019, and the subsequent COVID-19 pandemic, has led to substantial mortality, together with mass global disruption. There is an urgent need for novel antiviral drugs for therapeutic or prophylactic application. Cathepsin L is a key host cysteine protease utilized...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:bioRxiv
Huvudupphovsmän: Ashhurst, Anneliese S., Tang, Arthur H., Fajtová, Pavla, Yoon, Michael, Aggarwal, Anupriya, Stoye, Alexander, Larance, Mark, Beretta, Laura, Drelich, Aleksandra, Skinner, Danielle, Li, Linfeng, Meek, Thomas D., McKerrow, James H., Hook, Vivian, Tseng, Chien-Te K., Turville, Stuart, Gerwick, William H., O’Donoghue, Anthony J., Payne, Richard J.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Cold Spring Harbor Laboratory 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781308/
https://ncbi.nlm.nih.gov/pubmed/33398273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.12.23.424111
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk